Literature DB >> 33712301

Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol 2021;79:263-82.

Finn Edler von Eyben1.   

Abstract

Entities:  

Year:  2021        PMID： 33712301     DOI： 10.1016/j.eururo.2021.02.042

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.

Authors:  Wenfeng Lin; Chaoming Li; Naijin Xu; Masami Watanabe; Ruizhi Xue; Abai Xu; Motoo Araki; Ruifen Sun; Chunxiao Liu; Yasutomo Nasu; Peng Huang
Journal:  Int J Nanomedicine       Date:  2021-04-12

2.  A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.

Authors:  Seonggyu Byeon; Hongsik Kim; Hwang Gyun Jeon; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee; Soon Il Lee; Se Hoon Park
Journal:  BMC Cancer       Date:  2021-11-29       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.